dose escalation - Robuta Search

https://www.trialx.com/clinical-trials/listings/327772/a-phase-iiia-open-label/ A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the... Clinical trial for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma , A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to... phase i single center dose escalation iia open https://profiles.wustl.edu/en/publications/phase-i-open-label-dose-escalation-study-of-the-safety-pharmacoki/ Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and... phase i dose escalation the safety open label https://ctv.veeva.com/study/trivalent-rha-dose-escalation-study-in-elderly-subjects Trivalent rHA Dose Escalation Study in Elderly Subjects This study will compare the safety and immunogenicity of three different dose levels of an experimental recombinant influenza HA protein vaccine to a standard... dose escalation trivalent rha study elderly https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/1362/phase-1-first-in-human/?qd=34627423 A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety... New life-saving treatments for Urothelial Carcinoma, solid tumors in clinical trial on A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study... dose escalation the safety phase first human https://digitalcommons.providence.org/publications/9135/ "A secukinumab dose-escalation study in patients with ankylosing spondy" by Atul Deodhar, Alan J... Objective: To investigate the clinical response at week 52 in patients with ankylosing spondylitis (AS) who received secukinumab 300 vs 150 mg after inadequate... dose escalation in patients study atul alan https://pure.fujita-hu.ac.jp/en/publications/phase-i-dose-escalation-clinical-trial-of-hf10-oncolytic-herpes-v/ Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with... phase i dose escalation clinical trial herpes virus japanese https://multimedia.asrs.org/media/a-phase-1-multicenter-prospective-open-label-dose--22856 A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine... dose escalation phase prospective open label https://researchers.westernsydney.edu.au/en/publications/phase-i-dose-escalation-study-to-determine-the-safety-tolerabilit/ Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and... phase i dose escalation the safety study determine https://www.ijpsonline.com/abstract/a-phase-i-dose-escalation-study-of-apatinib-combinated-with-docetaxel-as-secondline-therapy-for-advanced-gastric-carcino-4261.html A Phase I Dose Escalation Study of Apatinib Combinated with | 4261 A bi-monthly Journal, which publishes original research works that contributes significantly to further the scientific knowledge in Pharmaceutical Sciences phase i dose escalation study https://www.canceropole-est.org/la-recherche-au-sein-du-canceropole-est/annuaires/publications-scientifiques/detail/?id=28231 A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in... phase i dose escalation study using simultaneous https://courageousparentsnetwork.org/videos/clinical-trials-dose-escalation-phase-by-phase/ Clinical Trials: Dose escalation, Phase by Phase - Courageous Parents Network clinical trials dose escalation phase courageous parents https://scholars.houstonmethodist.org/en/publications/treatment-of-aspirin-resistant-patients-with-omega-3-fatty-acids-/ Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation -... fatty acids dose escalation treatment aspirin resistant https://www.clinrol.com/study/170 A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of... This study evaluates AZD8421 alone and with targeted anti-cancer drugs in ER+HER2- advanced breast cancer and metastatic ovarian cancer patients. dose escalation the safety first human expansion https://amportal.astro.org/sessions/ss-31-21561/phase-i-pre-operative-single-fraction-dose-escalation-ablative-stereotactic-partial-breast-ir-106418 Phase I Pre-Operative Single Fraction Dose Escalation Ablative Stereotactic Partial Breast... phase i dose escalation pre operative single https://www.surveymonkey.com/r/DQD3V7W Dose escalation in prostate cancer Survey dose escalation prostate cancer survey https://adisinsight.springer.com/trials/700392707?error=cookies_not_supported&code=7baf86e5-90f0-436c-8393-58345c6cb976 A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of TRX-100 Tablets Evaluating... This is a Phase 1b, randomized, double-blind, placebo-controlled, dose escalation study of TRX-100 tablets evaluating the safety, pharmacokinetics, and food double blind dose escalation placebo controlled study https://www.dana-farber.org/clinical-trials/19-467 A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients... Phase 1 dose escalation will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of revumenib in participants with acute leukemia.... dose escalation cohort study in patients phase open https://christie.openrepository.com/entities/publication/9f7f235e-ef8f-4cc0-a40f-fe0eaff5643d 383P A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced... phase i dose escalation the novel in patients study https://www.avera.org/research-and-clinical-trials/clinical-trials/detail/?id=185 MER-XMT-1660-1: A Phase 1, First-in-Human, Dose Escalation and Expansion, Multicenter Study of... A Study of XMT-1660 in Solid Tumors dose escalation mer phase first human https://scholars.duke.edu/grant/274535 Scholars@Duke grant: A Phase II multicenter, open-label, single-arm dose escalation study of... phase ii single arm dose escalation scholars duke https://visualping.io/pages/blu-5937-dose-escalation-in-chronic-cough-clinical-trial-alerts-4961392 BLU-5937 Dose Escalation in Chronic Cough Clinical Trial: Get alerts for the latest updates -... See the latest updates to BLU-5937 Dose Escalation in Chronic Cough Clinical Trial. Subscribe for free to get alerts when changes are detected to BLU-5937 Dose... for the latest dose escalation chronic cough clinical trial get alerts https://www.prnewswire.com/news-releases/zhongze-therapeutics-announces-successful-completion-of-the-first-in-human-dose-escalation-study-of-zz6398-in-healthy-volunteers-301515620.html?tc=eml_cleartime Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of... /PRNewswire/ -- Zhongze Therapeutics, a clinical stage biotech company focused on the discovery, development and commercialization of innovative and... the first dose escalation therapeutics announces successful https://scholars.uky.edu/en/publications/a-multicenter-phase-12a-dose-escalation-study-of-the-antioxidant-/fingerprints/ A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin e... dose escalation the antioxidant phase study moiety https://www.knowcancer.com/cancer-trials/NCT01014936/ First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor EMD 1214063 in Subjects With Advanced... This is a an open-label, dose-escalation, first-in-man (FIM) study designed to explore EMD 1214063, in patients with advanced solid tumors who have not dose escalation first man trial met https://www.epistemonikos.org/en/documents/cb02aff319d7732930ef2b4a533fc1f530ae91db Chinese Multiple Dose Escalation (MDE) High Dose Study A Phase 1 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Cotadutide in Overweig... dose escalation chinese multiple mde high https://forums.mhra.gov.uk/showthread.php?1734-Suitability-of-targeted-SDV-of-data-collated-into-the-dose-escalation-interim-report&s=990f87dd17cc715be8ce6ece5103e310 Suitability of targeted SDV of data collated into the dose escalation interim report My questions is regarding how to interpret the MHRA recommendation (Grey guide section 12.6.2) that there should be a clear quality control (QC) process to... targeted sdv the dose interim report suitability data https://fis.tu-dresden.de/portal/de/publications/onestrength-dose-escalation-of-house-dust-mite-depot-product-for-subcutaneous-immunotherapy-is-safe-and-tolerable(5f4c8596-a18d-4560-b0c2-eb01b493fb30).html One-strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is... dose escalation house dust one strength mite https://lifestyle.all80sz1063.com/story/174412/salubris-biotherapeutics-presents-phase-1-2-dose-escalation-and-expansion-cohort-data-for-jk06-5t4-targeted-antibody-drug-conjugate-at-the-american-association-for-cancer-research-annual-meeting/ Salubris Biotherapeutics Presents Phase 1/2 Dose Escalation and Expansion Cohort Data for JK06,... dose escalation biotherapeutics presents phase expansion https://researchworks.creighton.edu/esploro/outputs/journalArticle/Phase-I-Three-Dimensional-Conformal-Radiation-Dose/991006262305902656 Phase I Three-Dimensional Conformal Radiation Dose Escalation Study in Newly Diagnosed... Mar 1, 2009 - To evaluate in a Phase I trial the feasibility and toxicity of dose-escalated three-dimensional conformal radiotherapy (3D-CRT) concurrent with chemotherapy in... phase i three dimensional dose escalation newly diagnosed radiation https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00531/full Frontiers | Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma Background and purposePediatric ependymoma carries a dismal prognosis, mainly owing to local relapse within RT fields. The current prospective European appro... dose escalation in patients frontiers feasibility pediatric https://checkorphan.org/clinicaltrial/safety-and-dose-escalation-study-of-an-adeno-associated-viral-vector-for-gene-transfer-in-hemophilia-a-participants/ Safety and Dose Escalation Study of an Adeno-Associated Viral Vector for Gene Transfer in... dose escalation viral vector gene transfer safety study https://repository.icr.ac.uk/items/7177c11c-d472-4f8b-8cd6-12f078eab40a Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced... BACKGROUND: Ripretinib 150 mg once daily (QD) is indicated for advanced gastrointestinal stromal tumors (GISTs) as at least fourth-line therapy. In INVICTUS,... dose escalation disease progression clinical benefit ripretinib https://pubmed.ncbi.nlm.nih.gov/26531095/ Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on... This clinical trial was registered on clinicaltrials.gov [NCT00908297] on May 21, 2009. dose escalation coenzyme study hemodialysis patients https://app.quri.ai/trials/NCT06541639/evm16cx01-first-in-human-dose-escalation-and-expansion-study EVM16CX01: First-in-Human, Dose-Escalation, and Expansion Study Evaluating the Safety,... Connect with this clinical trial through Quri.ai's free matching service. EVM16CX01: First-in-Human, Dose-Escalation, and Expansion Study Evaluating the... dose escalation the safety first human expansion https://jdc.jefferson.edu/medoncfp/57/ "Phase I dose-escalation study of the mTOR inhibitor sirolimus and the " by Haeseong Park, Ignacio... Preclinical models suggest that histone deacetylase (HDAC) and mammalian target of rapamycin (mTOR) inhibitors have synergistic anticancer activity. We... phase i dose escalation and by study mtor https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/a-phase-iib-openlabel-dose-escalation A Phase I/Ib Open-Label, Dose Escalation, First-in-Human Study to Evaluate the Safety,... A Phase I/Ib Open-Label, Dose Escalation, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-leukemic Activity... phase i dose escalation human study the safety ib https://www.page-meeting.org/Abstracts/informative-study-designs-the-value-of-within-subject-dose-escalation-in-the-espresso-design/ Informative study designs: The value of within-subject dose-escalation in the 'Espresso design' Oct 21, 2025 - Poster: Methodology - Study Design - Informative study designs: The value of within-subject dose-escalation in the 'Espresso design' study designs the value dose escalation informative within https://her2support.org/vbulletin/showthread.php?s=10f677107545a79afd337db8730a3deb&p=310524 Phase I Dose-escalation Trial of ARRY-380 in Combination With Trastuzumab in Particip - HER2... Phase I Dose-escalation Trial of ARRY-380 in Combination With Trastuzumab in Particip Clinical Trials phase i dose escalation trial arry combination https://siidon.guttmann.com/es/registro/randomized-dose-escalation-trial-elamipretide-adults-primary-mitochondrial-myopathy Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. |... dose escalation mitochondrial myopathy trial adults primary https://aesnet.org/abstractslisting/a-phase-2-dose-escalation-study-of-levetiracetam-in-the-treatment-of-neonatal-seizures-preliminary-results a phase 2 dose escalation study of levetiracetam in the treatment of neonatal seizures: preliminary... dose escalation the treatment phase study levetiracetam https://pure.psu.edu/en/publications/phase-i-dose-escalation-study-of-temsirolimus-in-combination-with/ Phase I dose escalation study of temsirolimus in combination with metformin in patients with... phase i dose escalation study combination metformin https://www.biospace.com/magenta-therapeutics-voluntarily-pauses-the-mgta-117-phase-1-2-dose-escalation-clinical-trial-to-investigate-drug-safety Magenta Therapeutics Voluntarily Pauses the MGTA-117 Phase 1/2 Dose-Escalation Clinical Trial to... Jan 25, 2023 - Magenta Therapeutics (Nasdaq: MGTA) today announced that the latest participant dosed at the Cohort 3 level (0.08 mg/kg) in the ongoing MGTA-117 Phase 1/2... dose escalation clinical trial magenta therapeutics pauses https://www.oncolink.org/oncolink-library/journal-scans/non-small-cell-lung-cancer/toxicity-and-outcome-results-of-rtog-93-11-a-phase-i-ii-dose-escalation-study-using-three-dimensional-conformal-radiotherapy-in-patients-with-inoperable-non-small-cell-lung-carcinoma Toxicity and Outcome Results of RTOG 93-11: A Phase I-II Dose-Escalation Study Using... OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing... results of phase i dose escalation toxicity outcome https://www.texasoncology.com/clinical-trials/05377996-A-Phase-1-First-in-Human-Dose-Escalation-and-Expansion-Multicenter-Study-of-XMT-1660-in-Par A Phase 1, First-in-Human, Dose Escalation and Expansion, Multicenter Study of XMT-1660 in... Learn more about Phase I Clinical Trial for Solid Tumors at Texas Oncology. dose escalation phase first human expansion https://childrens.uvahealth.com/clinical-trials/trial/302054 Clinical Trials | A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Tolerability,... clinical trials dose escalation the safety phase open https://publicatt.unicatt.it/handle/10807/28445 A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with... phase i dose escalation in patients study iside https://iris.hunimed.eu/handle/11699/10484 SBRT Dose Escalation Phase II Study for Liver Metastases Using Volumetric Modulated Arc Therapy... dose escalation phase ii liver metastases arc therapy study https://researchinformation.umcutrecht.nl/en/publications/a-phase-i-dose-escalation-study-of-two-cycles-carboplatin-olapari/ A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy... phase i dose escalation study two cycles https://www.froedtert.com/clinical-trials/multicenter-phase-1-open-label-dose-escalation-and-expansion-study-azd0486?f%5B0%5D=category%3A27001&f%5B1%5D=condition%3A32661&f%5B2%5D=sub_category%3A16086&f%5B3%5D=sub_category%3A16091&f%5B4%5D=sub_category%3A16096 A Multicenter, Phase 1, Open-Label, Dose-Escalation and Expansion Study of AZD0486, a Bispecific... The study drug, TNB-486, is a bispecific antibody. An antibody is a Y shaped protein used by your body's immune system to identify and destroy natural foreign... dose escalation phase open label expansion https://www.hmpgloballearningnetwork.com/site/rheum/news/start-low-go-slow-dose-escalation-allopurinol Start-Low Go-Slow Dose Escalation of Allopurinol Researchers identified which patients with gout may require longer periods of prophylaxis when initiating treatment. Gout News start low go slow dose escalation allopurinol https://decentrialz.com/clinical-trials/NCT00000645/phase-dose-escalation-study-synthetic-hypericin-00000645 A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300... Hypericin is unlike other drugs presently being used to treat AIDS patients. Hypericin shows anti-HIV activity in test tube experiments. Each group of eight... phase i dose escalation less than study synthetic https://www.clinicaltrialsarena.com/news/sellas-aml-therapy/ SELLAS closes safety assessment in dose escalation trial of AML Apr 21, 2023 - SELLAS has concluded the safety assessment stage of the highest dose cohort of its Phase l dose escalation trial of GFH009. safety assessment dose escalation closes trial aml https://www.allclinicaltrials.com/study/NCT06169371?searchMetadata=eyJjb25kaXRpb24iOiJicmVhc3QtY2FuY2VyIiwic2VhcmNoQ2FyZFBvc2l0aW9uIjozfQ%3D%3D Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) This is a post-marketing single arm, phase IV trial in which patients with high-risk early-stage HR+HER2- breast cancer will receive adjuvant abemaciclib in... dose escalation abemaciclib maintain intensity ade